Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Current Leases (2019 - 2025)

Historic Current Leases for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $1.1 million.

  • Pulmonx's Current Leases rose 7134.24% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 7134.24%. This contributed to the annual value of $778000.0 for FY2024, which is 7469.1% down from last year.
  • According to the latest figures from Q3 2025, Pulmonx's Current Leases is $1.1 million, which was up 7134.24% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Current Leases registered a high of $3.4 million during Q3 2023, and its lowest value of $663000.0 during Q3 2024.
  • Moreover, its 5-year median value for Current Leases was $2.2 million (2021), whereas its average is $2.2 million.
  • Its Current Leases has fluctuated over the past 5 years, first soared by 8091.02% in 2022, then tumbled by 8070.43% in 2024.
  • Pulmonx's Current Leases (Quarter) stood at $2.2 million in 2021, then soared by 46.71% to $3.2 million in 2022, then dropped by 4.8% to $3.1 million in 2023, then crashed by 74.69% to $778000.0 in 2024, then surged by 46.02% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.1 million for Q2 2025, and $1.1 million during Q1 2025.